Emerging Opportunities in the Fibroblast Activation Protein Inhibitor Market
The Fibroblast Activation Protein Inhibitor Market is set for remarkable expansion, with projections estimating the market size to reach approximately USD 8.722 billion by 2035. With a compound annual growth rate (CAGR) of 9.72%, this sector is gaining momentum as it addresses critical areas in oncology and fibrosis treatment. The ongoing advancements in targeted therapies, coupled with...
0 التعليقات 0 المشاركات 12 مشاهدة 0 معاينة